Catawba Research (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.50 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 115.70%
- Profit Growth 1107.13%
- Ebitda 108.37%
- Net Worth 140.98%
- Total Assets 110.92%
About Catawba Research (India)
Catawba Research (India) Private Limited (CRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2019 (Five years and three months 17 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nicolaus Joseph, Lokesh Chaudhari, and Andrew Silverman serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100MH2019PTC331697
-
Company No.
331697
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Oct 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Catawba Research (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lokesh Chaudhari
|
Managing Director | 07-Sep-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nicolaus Joseph
|
Director | 05-Mar-2021 | Current |
|
Andrew Silverman
|
Director | 08-Jan-2024 | Current |
Financial Performance of Catawba Research (India).
Catawba Research (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 115.7% increase. The company also saw a substantial improvement in profitability, with a 1107.13% increase in profit. The company's net worth Soared by an impressive increase of 140.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Catawba Research (India)?
In 2020, Catawba Research (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Catawba Research (India)?
Catawba Research (India) has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catawba Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catawba Research (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
